Biostar Pharmaceuticals

Biostar Pharmaceuticals EBIT per Share

The EBIT per Share of Biostar Pharmaceuticals (BSPM) as of Nov 1, 2026 is -1.39 USD. In the previous year, EBIT per Share was -10.75 USD — a change of -87.03% (higher).

EBIT per Share

-1.39USD

YoY

-87.03%

Last updated:

EBIT per Share of Biostar Pharmaceuticals is 2016 -1.39 USD. EBIT per Share of Biostar Pharmaceuticals was 2015 -10.75 USD. It decreases by -87.03% higher compared to the previous year.

The Biostar Pharmaceuticals EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2009
12.11 USD
Jan 1, 2010
17.93 USD
Jan 1, 2011
13.52 USD
Jan 1, 2012
-14.14 USD
Jan 1, 2013
0.29 USD
Jan 1, 2014
-0.60 USD
Jan 1, 2015
-10.75 USD
Jan 1, 2016
-1.39 USD
The Biostar Pharmaceuticals EBIT per Share history
YEAREBIT per ShareYoY
-1.39USD-87.03%
-10.75USD+1,692.75%
-0.60USD-309.82%
0.29USD-102.02%
-14.14USD-204.58%
13.52USD-24.58%
17.93USD+48.04%
12.11USD+73.18%
6.99USD+64.50%
4.25USD+528.69%
0.68USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biostar Pharmaceuticals Stock analysis

What does Biostar Pharmaceuticals do? Biostar Pharmaceuticals Inc. is a leading Chinese biotechnology company that has been operating in the healthcare industry since 1992. The company focuses on the development and marketing of natural medicine and pharmaceutical products. Biostar Pharmaceuticals Inc. is headquartered in Xianyang, China and operates multiple manufacturing facilities and research institutions near Xianyang. Biostar Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biostar Pharmaceuticals stock

EBIT per Share of Biostar Pharmaceuticals is -1.39 USD in 2016.

EBIT per Share of Biostar Pharmaceuticals changed from -10.75 USD to -1.39 USD, representing a -87.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Biostar Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Biostar Pharmaceuticals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Biostar Pharmaceuticals